The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions

KAYHAN S., Gumus A., CINARKA H., Murat N., Yilmaz A., Bedir R., ...Daha Fazla

JOURNAL OF THORACIC DISEASE, cilt.5, sa.5, ss.634-640, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.3978/j.issn.2072-1439.2013.09.19
  • Dergi Adı: JOURNAL OF THORACIC DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.634-640
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background and objective: Recent evidence suggests that YKL-40 is a relatively new biomarker of inflammation and it is involved in the pathogenesis of several pulmonary diseases. Details of serum and pleural YKL-40 in pleural effusions however, remain unknown. We aimed to assess whether serum and pleural YKL-40 is an accurate biomarker of pleural effusions.